BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 32070368)

  • 1. Comprehensive analysis of the association between tumor glycolysis and immune/inflammation function in breast cancer.
    Li W; Xu M; Li Y; Huang Z; Zhou J; Zhao Q; Le K; Dong F; Wan C; Yi P
    J Transl Med; 2020 Feb; 18(1):92. PubMed ID: 32070368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of the Relationship Between Metabolic Reprogramming and Immune Function in Prostate Cancer.
    Xie W; Guo H; Zhang J; Hu L; Wu Y; Wang X
    Onco Targets Ther; 2021; 14():3251-3266. PubMed ID: 34040390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasculogenic mimicry regulates immune infiltration and mutational status of the tumor microenvironment in breast cancer to influence tumor prognosis.
    Zheng S; Guo G; Yang Z; Lu Y; Lu K; Fu W; Huang Q
    Environ Toxicol; 2024 May; 39(5):2948-2960. PubMed ID: 38308456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
    Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
    Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
    [No Abstract]   [Full Text] [Related]  

  • 5. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
    Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
    Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a novel glycolysis-related prognostic gene signature for ovarian cancer and its relationships with immune infiltration of the tumor microenvironment.
    Bi J; Bi F; Pan X; Yang Q
    J Transl Med; 2021 Sep; 19(1):382. PubMed ID: 34496868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment.
    Jiang Z; Liu Z; Li M; Chen C; Wang X
    EBioMedicine; 2019 Apr; 42():431-442. PubMed ID: 30935888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High FLT3 expression indicates favorable prognosis and correlates with clinicopathological parameters and immune infiltration in breast cancer.
    Chen R; Wang X; Fu J; Liang M; Xia T
    Front Genet; 2022; 13():956869. PubMed ID: 36159964
    [No Abstract]   [Full Text] [Related]  

  • 9. Systematic Analysis Uncovers Associations of PGK1 with Prognosis and Immunological Characteristics in Breast Cancer.
    Li L; Bai Y; Gao Y; Li D; Chen L; Zhou C; Feng M; Chen X; Jin W; Cao Y
    Dis Markers; 2021; 2021():7711151. PubMed ID: 34790279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
    J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring immune-related genes with prognostic value in microenvironment of breast cancer from TCGA database.
    Yang H; Zhao K; Kang H; Wang M; Wu A
    Medicine (Baltimore); 2020 Apr; 99(14):e19561. PubMed ID: 32243373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGK1 is a Potential Survival Biomarker and Invasion Promoter by Regulating the HIF-1α-Mediated Epithelial-Mesenchymal Transition Process in Breast Cancer.
    Fu D; He C; Wei J; Zhang Z; Luo Y; Tan H; Ren C
    Cell Physiol Biochem; 2018; 51(5):2434-2444. PubMed ID: 30537744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma.
    Ghatalia P; Gordetsky J; Kuo F; Dulaimi E; Cai KQ; Devarajan K; Bae S; Naik G; Chan TA; Uzzo R; Hakimi AA; Sonpavde G; Plimack E
    J Immunother Cancer; 2019 May; 7(1):139. PubMed ID: 31138299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas.
    Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC
    Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma.
    Chen DP; Ning WR; Jiang ZZ; Peng ZP; Zhu LY; Zhuang SM; Kuang DM; Zheng L; Wu Y
    J Hepatol; 2019 Aug; 71(2):333-343. PubMed ID: 31071366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
    Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
    BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune gene expression profiling reveals heterogeneity in luminal breast tumors.
    Zhu B; Tse LA; Wang D; Koka H; Zhang T; Abubakar M; Lee P; Wang F; Wu C; Tsang KH; Chan WC; Law SH; Li M; Li W; Wu S; Liu Z; Huang B; Zhang H; Tang E; Kan Z; Lee S; Park YH; Nam SJ; Wang M; Sun X; Jones K; Zhu B; Hutchinson A; Hicks B; Prokunina-Olsson L; Shi J; Garcia-Closas M; Chanock S; Yang XR
    Breast Cancer Res; 2019 Dec; 21(1):147. PubMed ID: 31856876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Development of Subtypes With Poor Prognosis in Pan-Gynecological Cancer Based on Gene Expression in the Glycolysis-Cholesterol Synthesis Axis.
    Wang G; Liu X; Wang D; Sun M; Yang Q
    Front Oncol; 2021; 11():636565. PubMed ID: 33842342
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer.
    Park IH; Kong SY; Ro JY; Kwon Y; Kang JH; Mo HJ; Jung SY; Lee S; Lee KS; Kang HS; Lee E; Joo J; Ro J
    Clin Breast Cancer; 2016 Feb; 16(1):51-8. PubMed ID: 26364145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatic profiling of prognosis-related genes in the breast cancer immune microenvironment.
    Bai F; Jin Y; Zhang P; Chen H; Fu Y; Zhang M; Weng Z; Wu K
    Aging (Albany NY); 2019 Nov; 11(21):9328-9347. PubMed ID: 31715586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.